Prenatal diagnosis of hypoplastic left heart syndrome in current era
- PMID: 21624547
- DOI: 10.1016/j.amjcard.2011.03.065
Prenatal diagnosis of hypoplastic left heart syndrome in current era
Abstract
We sought to evaluate the relation of a prenatal diagnosis (preDx) with morbidity and mortality during the initial hospitalization in a contemporary cohort of patients with hypoplastic left heart syndrome (HLHS). A retrospective study of patients with HLHS presenting from 1999 to 2010 was performed. Patients with genetic disorders or a gestational age <34 weeks or who had intentionally received comfort care only were excluded. Of the 81 patients meeting the study criteria, 49 had a preDx and 32 were diagnosed postnatally (postDx). Birth weight (median 3.0 vs 3.4 kg; p = 0.007) and gestational age (median 38 vs 39 weeks; p <0.001) were lower in the preDx than in the postDx patients. Preoperatively, the postDx patients were intubated more frequently (97% vs 71%, p = 0.004) and ventilated longer (median 96 vs 24 hours, p = 0.005) than the preDx patients. They also had more preoperative acidosis, multiorgan failure, tricuspid valve regurgitation, and right ventricular dysfunction. Of the 73 patients undergoing surgery, no difference in survival was seen between the preDx and postDx groups (91% vs 89%). The median duration of postoperative ventilation was 7 days and the median length of stay was 36 days for the 66 survivors, with no difference between the 2 groups. Postoperative morbidities, including chylothorax and infection, were also similar in the preDx and postDx patients. No studied preoperative factor was associated with death, duration of postoperative ventilation, or length of stay. In conclusion, our recent experience has shown that preDx of HLHS was not associated with a survival advantage, fewer postoperative complications, or shorter length of stay. Improved preoperative status was observed in the preDx patients; however, they were born earlier with a lower birthweight. What effect these factors might have on longer term morbidity remains unknown.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at Fontan completion.J Thorac Cardiovasc Surg. 2010 Sep;140(3):537-44. doi: 10.1016/j.jtcvs.2010.03.045. J Thorac Cardiovasc Surg. 2010. PMID: 20723722
-
Early postoperative outcomes in a series of infants with hypoplastic left heart syndrome undergoing stage I palliation operation with either modified Blalock-Taussig shunt or right ventricle to pulmonary artery conduit.Pediatr Crit Care Med. 2006 May;7(3):238-44. doi: 10.1097/01.PCC.0000201003.38320.63. Pediatr Crit Care Med. 2006. PMID: 16474256
-
Risk factors for mortality after the Norwood procedure using right ventricle to pulmonary artery shunt.Ann Thorac Surg. 2009 Jan;87(1):178-85; discussion 185-6. doi: 10.1016/j.athoracsur.2008.08.027. Ann Thorac Surg. 2009. PMID: 19101293
-
Hypoplastic left heart syndrome: current considerations and expectations.J Am Coll Cardiol. 2012 Jan 3;59(1 Suppl):S1-42. doi: 10.1016/j.jacc.2011.09.022. J Am Coll Cardiol. 2012. PMID: 22192720 Free PMC article. Review.
-
Informed consent, bioethical equipoise, and hypoplastic left heart syndrome.Cardiol Young. 2011 Dec;21 Suppl 2:133-40. doi: 10.1017/S1047951111001715. Cardiol Young. 2011. PMID: 22152540 Review.
Cited by
-
Practice variations for fetal and neonatal congenital heart disease within the Children's Hospitals Neonatal Consortium.Pediatr Res. 2023 May;93(6):1728-1735. doi: 10.1038/s41390-022-02314-2. Epub 2022 Sep 27. Pediatr Res. 2023. PMID: 36167818
-
Addressing Social Determinants of Health and Mitigating Health Disparities Across the Lifespan in Congenital Heart Disease: A Scientific Statement From the American Heart Association.J Am Heart Assoc. 2022 Apr 19;11(8):e025358. doi: 10.1161/JAHA.122.025358. Epub 2022 Apr 7. J Am Heart Assoc. 2022. PMID: 35389228 Free PMC article. Review.
-
Prenatal Counseling of Fetal Congenital Heart Disease.Curr Treat Options Cardiovasc Med. 2017 Jan;19(1):5. doi: 10.1007/s11936-017-0502-1. Curr Treat Options Cardiovasc Med. 2017. PMID: 28197939 Review.
-
The significance of an integrated management mode of prenatal diagnosis-postnatal treatment for critical congenital heart disease in newborns.Cardiovasc Diagn Ther. 2021 Apr;11(2):447-456. doi: 10.21037/cdt-20-892. Cardiovasc Diagn Ther. 2021. PMID: 33968622 Free PMC article.
-
Fetal Intelligent Navigation Echocardiography (FINE) Detects 98% of Congenital Heart Disease.J Ultrasound Med. 2018 Nov;37(11):2577-2593. doi: 10.1002/jum.14616. Epub 2018 Mar 30. J Ultrasound Med. 2018. PMID: 29603310 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical